01443-4/asset/ae270f4a-805d-43ab-aa80-4effc52cdd4f/main.assets/gr3_lrg.jpg)
tirzepatide sglt2 Once-weekly versus once-daily insulin degludec as add-on to metformin with or without inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial Tirzepatide and Cardiovascular Outcomes: A
Description
Although Retatrutide has demonstrated outstanding results in clinical trials, it is still awaiting regulatory approval
Early pregnancy, particularly the first trimester, is the period of greatest fetal vulnerability to medication exposure
According to the FDA prescribing information for Zepbound, in the SURMOUNT-1 trial, cholelithiasis was reported in 2.5% of patients receiving tirzepatide compared to 1.0% of patients on placebo
Mechanism of action Both Mounjaro and Wegovy work by targeting hormones involved in appetite, blood sugar control, and digestion
